The Great Lakes Regional Center of Excellence for Biodefense and Emerging Diseases Research (GLRCE) at the University of Chicago, is one of eleven National Institute of Allergy and Infectious Diseases supported centers for public health and biodefense research. The mission of the GLRCE is to develop novel vaccines, therapeutics and adjuvants to combat microbiological agents identified as having the potential to pose a severe threat to public health and safety.
The GLRCE seeks research project applications from groups of investigators with differing areas of expertise who can collaborate in research thereby pooling their talents and resources resulting in synergistic research programs that are designed to achieve results that may not otherwise be attainable by investigators working independently. The GLRCE is open to proposals that cover all biothreat agents indicated by NIAID list above but is especially interested in recruiting projects in the following two areas:
- Antibiotic resistant bacteria, and
- New therapeutic strategies to enhance innate immune responses and resistance to microbial infections.
Applications are due September 1, 2011. Awards are granted similar to R01 in costs per year and will be subject to non-competitive renewal in the following years. In recognition of the fact that excellent research is not necessarily regional, GLRCE is inviting applications from all Regional Centers of Excellence, including OHSU. Refer to the full announcement for more information on eligibility.
View the rest of this week’s Funding Alerts.